d-alpha tocopherol has been researched along with Osteonecrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreis, JD; Claudino, M; Delfrate, G; Fernandes, D; Franco, GCN; Lipinski, LC; Mecca, LEA; Mroczek, T | 1 |
| Arai, Y; Fujioka, M; Goto, T; Ishida, M; Kubo, T; Kuribayashi, M; Takahashi, KA | 1 |
| Berenson, JR; Epstein, JB; Epstein, MS; Gorsky, M; Wicknick, FW | 1 |
| Jayaram, R; Thavarajah, M | 1 |
4 other study(ies) available for d-alpha tocopherol and Osteonecrosis
| Article | Year |
|---|---|
Effect of pentoxifylline and α-tocopherol on medication-related osteonecrosis of the jaw in rats: Before and after dental extraction.
Topics: alpha-Tocopherol; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Osteonecrosis; Pentoxifylline; Rats; Rats, Wistar; Tooth Extraction | 2022 |
Vitamin E prevents steroid-induced osteonecrosis in rabbits.
Topics: alpha-Tocopherol; Animals; Disease Models, Animal; Femur Head Necrosis; Glucocorticoids; Male; Methylprednisolone; Osteonecrosis; Rabbits; Vitamins | 2010 |
Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Tocopherol; Anti-Infective Agents, Local; Antioxidants; Bone Density Conservation Agents; Chlorhexidine; Diphosphonates; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Mouthwashes; Osteonecrosis; Pentoxifylline; Phosphodiesterase Inhibitors; Treatment Outcome | 2010 |
Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bone Density Conservation Agents; Free Radical Scavengers; Humans; Male; Mandible; Osteonecrosis; Pentoxifylline; Prostatic Neoplasms; Vitamin E; Zoledronic Acid | 2019 |